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Arrhythmias and particulate matter
There is strong epidemiological evidence that inhalation 
of combustion-derived soot triggers life-threatening 
cardiovascular events. Indeed, the 2015 Global Burden 
of Disease estimated that 1 521 000 (35%) of the total 
of 4 241 000 deaths attributable to ambient particulate 
matter (PM; all causes) were from ischaemic heart 
disease.1 But policy makers continue to regard these 
mortality figures with scepticism, and delay enacting 
the urgent interventions that will significantly reduce 
population exposure to air pollution. For example in 
the UK, there is no national plan to replace the present 
highly polluting fleet of diesel cars, vans, and taxis. 
Potential reasons for this scepticism include difficulty 
in communicating to non-specialists the methods used 
to attribute deaths to air pollution,2 and the absence of 
experimental data directly linking inhalation of PM to 
cardiovascular disturbances known to cause fatal events. 
The study by Franco Folino and colleagues, addresses 
this latter issue by linking air pollution data from the 
Vento region of Italy with ventricular arrhythmia data 
stored by implanted defibrillators. Folino and colleagues 
report a significant association between episodes 
of ventricular tachycardia and ventricular fibrillation 
and PM of less than 2·5 μm in aerodynamic diameter 
(PM2·5),3 a result that both strengthens the case for 
a causal association between PM and cardiovascular 
deaths, and suggests further innovative studies. First, 
by adding personal carbonaceous PM monitoring to 
this group of high-risk patients (figure), it should be 
possible to determine the independent association 
between locally generated traffic PM and arrhythmias. 
Second, contribution of fossil fuel and wood smoke 
to background PM in the Vento region offers a way of 
assessing the effect of different types of PM. Indeed, 
in-vitro toxicity studies suggest that not all particles are 
equal. For example, wood smoke PM, compared with 
diesel PM, induces higher levels of oxidative damage 
to human umbilical endothelial cells and stimulates 
increased monocyte adhesion.4 Normally, ambient 
black carbon from fossil-fuel combustion is measured 
by an aethalometer using infrared light absorption. 
However, some of the larger aethalometers also assess 
ultra-violet light absorption, a spectrum that detects 
aromatic organic compounds found in wood smoke 
and other biomass sources. Thus, light absorption 
from both wavelengths could be used to identify the 
independent effect of background wood smoke PM 
on arrhythmias—a result that would be highly relevant 
to exposures in low-income countries, where wood 
burning is a major source of personal exposure to 
carbonaceous PM.5 
What should clinicians tell high-risk cardiovascular 
patients about air pollution? To date, management 
guidelines provide little or no guidance. A recent 
workshop hosted by the European Respiratory Society 
addressed this question and identified two major 
areas that should be considered by future guidelines.6 
First, patients should understand how acute episodes 
of poor air quality will affect their own health, and 
the actions they need to take to protect themselves. 
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Figure: Data from a portable aethalometer carried for 24 h by an adult working in London (UK) 
Peaks of black carbon (BC; ng/m3) exposure occur during commuting, with relatively low exposures at the home address (2100 h to 0600 h). 
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Second, health-care providers need the tools to advise 
patients about air pollution and how to change their 
treatment plans or activities on high pollution days, 
and how to reduce long-term exposure.6 In some cities, 
patients are able to sign up to text message services 
that warn about pollution and provide advice about 
how to reduce short-term risk. For example, London’s 
airText’s advice to adults with heart problems on very 
high pollution days is to “avoid strenuous physical 
activity”.7 It remains unclear, however, whether 
this, albeit sensible, advice reduces the daily dose of 
particles inhaled into the lungs. Use of a facemask on 
high pollution days is another option that patients are 
increasingly asking clinicians about. Facemasks are 
socially acceptable in countries such as China, and are 
widely used by urban cyclists in many other countries. 
Preliminary evidence for the efficacy of facemasks was 
provided by a randomised crossover trial8 of patients 
with coronary heart disease who walked a predefined 
route in central Beijing, China, with and without a 
facemask. The study found that the facemask was well 
tolerated, reduced maximal ST segment depression, and 
increased heart rate variability.8 Avoidance of pollution 
hotspots from local road traffic is a possible way of 
reducing long-term exposure. The UK charity Global 
Action Plan combined short-term and long-term advice 
in its patient information pack.9 The pack includes a 
map of local high-pollution streets, and recommends 
regular use of less polluted routes (using the map), 
travel outside the rush hour, and regular checking of 
the daily air pollution forecast. In summary, we urgently 
need more evidence to identify the most effective 
personal exposure reduction strategies. In developing 
this evidence, clinicians should not forget to continue to 
challenge governments to implement national policies 
that significantly reduce air pollution. 
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